The rising cost of specialty drugs continues to put pressure on all stakeholders. Specialty pharmacists can fill an existing gap in compliance and cost control.
Molly Burich, MS
Advertisement
Articles by Molly Burich, MS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves XFG-Adapted COVID-19 Vaccine, mRNA for the 2026-2027 Season
2
FDA Approves Bixlenvo Once-Daily Single-Tablet Regimen for Virologically Suppressed Adults With HIV
3
What Heidi Overton's FDA Nomination Could Mean for Pharmacy
4
Beyond the Transplant Center: IV Therapy in the Community
5